Provided by Tiger Trade Technology Pte. Ltd.

LAVA Therapeutics N.V.

1.74
0.0000
Volume:- -
Turnover:505.30K
Market Cap:45.77M
PE:-2.02
High:1.74
Open:1.74
Low:1.74
Close:1.74
52wk High:2.00
52wk Low:0.8502
Shares:26.31M
Float Shares:10.22M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8620
EPS(LYR):-0.9359
ROE:-101.51%
ROA:-19.92%
PB:3.61
PE(LYR):-1.86

Loading ...

XOMA Royalty Corp: Offer Extended Until One Minute After 11:59 P.m. Eastern Time on Oct 17

THOMSON REUTERS
·
Oct 03, 2025

XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.

GlobeNewswire
·
Oct 03, 2025

LAVA Therapeutics Postpones EGM for XOMA Deal

TIPRANKS
·
Sep 30, 2025

LAVA Therapeutics Nv Says Egm Is Expected to Be Reconvened by Early November 2025

THOMSON REUTERS
·
Sep 30, 2025

LAVA Therapeutics Nv Says Decided to Cancel Extraordinary General Meeting of Shareholders Scheduled to Occur on September 30

THOMSON REUTERS
·
Sep 30, 2025

LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025

GlobeNewswire
·
Sep 30, 2025

Versant Venture Capital VI, L.P. Reports Disposal of Common Shares of LAVA Therapeutics NV

Reuters
·
Sep 24, 2025

Major Shareholder Sells Millions in LAVA Therapeutics Stock!

TIPRANKS
·
Sep 19, 2025

LAVA Therapeutics NV Announces Date for Extraordinary General Meeting

Reuters
·
Sep 04, 2025

LAVA Therapeutics NV Announces Date for Extraordinary General Meeting of Shareholders

Reuters
·
Aug 23, 2025

LAVA Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 18, 2025

LAVA Therapeutics NV expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
Aug 15, 2025

LAVA Therapeutics Q2 EPS $(0.32) Misses $(0.26) Estimate

Benzinga
·
Aug 14, 2025

LAVA Therapeutics Q2 Basic EPS USD -0.32

THOMSON REUTERS
·
Aug 14, 2025

XOMA Royalty Corporation Reports Q2 2025 Net Income of $9.2M, Cash Receipts Rise to $11.7M

Reuters
·
Aug 13, 2025

Lava Therapeutics Is Maintained at Neutral by HC Wainwright & Co.

Dow Jones
·
Aug 06, 2025

LAVA Therapeutics N.v. : H.c. Wainwright Cuts Target Price to $1.24 From $1.5

THOMSON REUTERS
·
Aug 05, 2025

LAVA Therapeutics Nv : Jefferies Cuts to Hold From Buy; Cuts Target Price to $1.5 From $3

THOMSON REUTERS
·
Aug 05, 2025

XOMA Royalty Corp: LAVA to Initiate Wind-Down of LAVA-1266 Program

THOMSON REUTERS
·
Aug 04, 2025

XOMA Royalty Corp - Acquisition Includes CVR for 75% of Net Proceeds

THOMSON REUTERS
·
Aug 04, 2025